How Weight-Loss Drugs Could Impact U.S. Healthcare and Food. Plus, the Biggest Problems With GLP1s.

How Weight-Loss Drugs Could Impact U.S. Healthcare and Food. Plus, the Biggest Problems With GLP1s.

Today’s episode is our second in a series on the weight-loss drug revolution of the last two years. On Tuesday, we talked to endocrinologist Beverly Tchang about the science of glucagon like peptide 1 receptor agonists—also known as GLP1s, also known as Ozempic, Wegovy, Moujargo, and Zepbound. If you haven’t listened to that show, I think you’ll feel safe and entertained within the bounds of this episode. But if you want to know more about how these drugs work, their effect on insulin and glucose and the brain’s reward center, or the questions they raise about obesity and the nature of willpower and free will, I’d encourage you to queue up that show. Today, in Part 2, we have two guests: Zach Reitano is the CEO and cofounder of the telehealth platform Ro. He is here for a couple reasons. He has a bird’s-eye view of the GLP1 marketplace, the rise in demand, the supply chain, the economics of pricing and insurance. He’s also written several revelatory essays, pulling in research from think tanks, medical experts, and investment banks, that have helped shape my understanding of these drugs and the effect they could have on the population and the economy. Our second guest is Dr. Robert Lustig, an endocrinologist who spent years as a pediatrician and researcher at the University of California-San Francisco. As you’ll hear, he is much less optimistic about the ability of these drugs to revolutionize obesity medication in America. If you have questions, observations, or ideas for future episodes, email us at PlainEnglish@Spotify.com. Host: Derek Thompson Guests: Zach Reitano & Robert Lustig Producer: Devon Baroldi Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episoder(363)

True or False: 10 Controversial Predictions About the Future of Streaming, Tech, and Media

True or False: 10 Controversial Predictions About the Future of Streaming, Tech, and Media

Last year was a bloodbath for media of all stripes. Netflix crashed, the advertising market cratered, Disney fired a CEOBob and replaced him with a CEOBob, and meanwhile, the domestic box office for f...

13 Jan 202340min

Why There Is So Much Bullsh*t in Science

Why There Is So Much Bullsh*t in Science

We should be living in a golden age of creativity in science and technology. We know more about the universe and ourselves than we did in any other period in history, and with easy access to superior ...

11 Jan 20231h

The 2023 Economy FAQ: Is Recession Inevitable? Will Housing Crash? Can Tech Recover?

The 2023 Economy FAQ: Is Recession Inevitable? Will Housing Crash? Can Tech Recover?

Michael Batnick and Ben Carlson of Ritholtz Wealth Management rejoin the pod to talk about what they learned from the topsy-turvy 2022 economy and make predictions about 2023 markets. If you have ques...

4 Jan 202344min

PE Greatest Hits: Thompson and Klosterman Debate Why Society Got So Negative

PE Greatest Hits: Thompson and Klosterman Debate Why Society Got So Negative

This has been an amazing year for the show, and I’m so grateful for everybody who has listened. I’m off the last two weeks of the year but I wanted to keep something in your feed over the holidays, so...

27 Des 202249min

PE Greatest Hits: Derek and Ryen Debate the Most Impressive Sports Statistic of All Time

PE Greatest Hits: Derek and Ryen Debate the Most Impressive Sports Statistic of All Time

This has been an amazing year for the show, and I’m so grateful for everybody who has listened. I’m off the last two weeks, but I wanted to keep something in your feed over the holidays, so this week ...

20 Des 202253min

ChatGPT, Obesity Drugs, Exoplanet Images, and Medical Miracles: The Most Amazing Breakthroughs of 2022

ChatGPT, Obesity Drugs, Exoplanet Images, and Medical Miracles: The Most Amazing Breakthroughs of 2022

Derek talks to economist and writer Eli Dourado about the most exciting scientific and technological discoveries of the year, from the AI toys that everybody seems to be playing with to lesser-known b...

13 Des 202258min

Sperm Counts Are Falling All Over the World—Why?

Sperm Counts Are Falling All Over the World—Why?

In the last 50 years, average sperm counts have fallen by 50 percent. This isn’t just happening in the U.S. or Europe or Asia. It seems to be happening everywhere. If the current rate of decline conti...

9 Des 202249min

Who's Afraid of a Four-Day Work Week?

Who's Afraid of a Four-Day Work Week?

4 Day Week Global is a nonprofit organization that recently conducted a trial with 33 companies and 900 workers that replaced the typical five-day week with a four-day work week with no change in pay....

6 Des 202251min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
lydartikler-fra-aftenposten
forklart
aftenpodden-usa
popradet
stopp-verden
i-retten
dine-penger-pengeradet
fotballpodden-2
det-store-bildet
rss-gukild-johaug
nokon-ma-ga
hanna-de-heldige
rss-ness
aftenbla-bla
e24-podden
rss-dannet-uten-piano
grasoner-den-nye-kalde-krigen
frokostshowet-pa-p5